Market Cap 1.80B
Revenue (ttm) 0.00
Net Income (ttm) -26.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 15,092,601
Avg Vol 8,119,992
Day's Range N/A - N/A
Shares Out 196.63M
Stochastic %K 85%
Beta 2.50
Analysts Strong Sell
Price Target $10.00

Company Profile

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is adm...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 200 5278
Address:
7 Times Square, Suite 2503, New York, United States
OnTheBalance
OnTheBalance Jun. 26 at 12:25 PM
$SLS @Hannibal_Smith yep, since IA, it's Sellas and its advisors who decided to collect the extra data, now at 18 months extra, to determine proportions of patients living past years 2, 3 and 4. They all keep receiving treatments for life. It's no longer like a regular TAM but like a Consumer products' growing reservoir customers. Getting bigger for years upon years and then expanding to include CR1. All living patients, and the river of death downstream turns into a trickle. $SLS
0 · Reply
Duncan74
Duncan74 Jun. 26 at 12:25 PM
$SLS Turn off share lending. You are the boss.
0 · Reply
vlucky16
vlucky16 Jun. 26 at 12:25 PM
$SLS This is the Big One!!
0 · Reply
Flkz
Flkz Jun. 26 at 12:25 PM
$SLS we halt today
0 · Reply
chuckieclam
chuckieclam Jun. 26 at 12:25 PM
$SLS AGAIN, where did all these shitbird cockroaches come from? they sniffed us out. they just float from losing money in bitcoin to losing money in tech stocks to stinkin up our beloved Sellas room..
0 · Reply
jennypeppers
jennypeppers Jun. 26 at 12:22 PM
$SLS waiting and watching for that T1 baby
0 · Reply
Johnmtnb2018
Johnmtnb2018 Jun. 26 at 12:21 PM
$SLS Let’s see if we get a T1 halt here before BO PR. Sellas has been working on a sale of the Co. since December 2025. This is not a data play anymore. Regal phase 3 data is beyond revolutionary, it will become the gold standard for oncology trials. BO coming !
0 · Reply
DWldn
DWldn Jun. 26 at 12:20 PM
$SLS Wanting a strong Weekly close today. Let's see if we get it. Above 10.98 is the Key Level. Then 15.08 could be in the scopes. Strong technicals and strong fundamentals.
2 · Reply
BamaWriter
BamaWriter Jun. 26 at 12:20 PM
$SLS I just removed 27k shares from share lending this morning. Maybe that will help a little. Well, technically I put in the request, but Fidelity told me the shares would be returned within a couple of hours.
0 · Reply
MRTunity
MRTunity Jun. 26 at 12:19 PM
$SLS THIS IS RETARDED WTF 🤷‍♂️ INTERACTIVE BROKERS SENT THIS EMAIL 📧 YESTERDAY AND AGAIN JUST NOW For the record: I have NEVER EVER nor would ever short a single share or even buy a single out contract so what is this bullshit?! Someone is f u c k e d + desperate this doesn’t explode 💥 🚀
1 · Reply
Latest News on SLS
SELLAS Life Sciences Group Transcript: AGM 2026

Jun 16, 2026, 8:30 AM EDT - 9 days ago

SELLAS Life Sciences Group Transcript: AGM 2026


SELLAS Life Sciences Group Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 6 weeks ago

SELLAS Life Sciences Group Quarterly report: Q1 2026


SELLAS Life Sciences Group Earnings release: Q1 2026

May 12, 2026, 7:00 AM EDT - 6 weeks ago

SELLAS Life Sciences Group Earnings release: Q1 2026


SELLAS Life Sciences Group Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

SELLAS Life Sciences Group Proxy statement: Proxy filing


SELLAS Life Sciences Group Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

SELLAS Life Sciences Group Proxy statement: Proxy filing


Sellas Life Sciences files automatic mixed securities shelf

2026-03-20T21:05:42.000Z - 3 months ago

Sellas Life Sciences files automatic mixed securities shelf


SELLAS Life Sciences Group Earnings release: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 3 months ago

SELLAS Life Sciences Group Earnings release: Q4 2025


SELLAS Life Sciences Group Annual report: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 3 months ago

SELLAS Life Sciences Group Annual report: Q4 2025


Sellas Life Sciences enters agreement with IMPACT-AML

2026-01-14T13:37:03.000Z - 5 months ago

Sellas Life Sciences enters agreement with IMPACT-AML


SELLAS Life Sciences Group Earnings release: Q3 2025

Nov 12, 2025, 4:00 PM EST - 8 months ago

SELLAS Life Sciences Group Earnings release: Q3 2025


SELLAS Life Sciences Group Quarterly report: Q3 2025

Nov 12, 2025, 4:00 PM EST - 8 months ago

SELLAS Life Sciences Group Quarterly report: Q3 2025


SELLAS Life Sciences Group Transcript: R&D Day 2025

Oct 29, 2025, 10:00 AM EDT - 8 months ago

SELLAS Life Sciences Group Transcript: R&D Day 2025


SELLAS Life Sciences Group Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 11 months ago

SELLAS Life Sciences Group Earnings release: Q2 2025


SELLAS Life Sciences Group Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 11 months ago

SELLAS Life Sciences Group Quarterly report: Q2 2025


SELLAS Life Sciences Group Proxy statement: Proxy Filing

Jun 10, 2025, 8:00 AM EDT - 1 year ago

SELLAS Life Sciences Group Proxy statement: Proxy Filing


SELLAS Life Sciences Group Earnings release: Q1 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

SELLAS Life Sciences Group Earnings release: Q1 2025


SELLAS Life Sciences Group Quarterly report: Q1 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

SELLAS Life Sciences Group Quarterly report: Q1 2025


SELLAS Life Sciences Group Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

SELLAS Life Sciences Group Proxy statement: Proxy Filing


SELLAS Life Sciences Group Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

SELLAS Life Sciences Group Proxy statement: Proxy Filing


SELLAS Life Sciences Group Earnings release: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

SELLAS Life Sciences Group Earnings release: Q4 2024


SELLAS Life Sciences Group Annual report: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

SELLAS Life Sciences Group Annual report: Q4 2024


SELLAS Announces Key Business Objectives for 2025

Jan 8, 2025, 8:20 AM EST - 1 year ago

SELLAS Announces Key Business Objectives for 2025


SELLAS Life Sciences Group Transcript: Study Update

Dec 10, 2024, 9:00 AM EST - 1 year ago

SELLAS Life Sciences Group Transcript: Study Update


SELLAS Life Sciences Group Press release: Study Update

Dec 10, 2024, 9:00 AM EST - 1 year ago

SELLAS Life Sciences Group Press release: Study Update


SELLAS Life Sciences Group Quarterly report: Q3 2024

Nov 13, 2024, 7:00 AM EST - 1 year ago

SELLAS Life Sciences Group Quarterly report: Q3 2024


SELLAS Life Sciences Group Earnings release: Q3 2024

Nov 13, 2024, 7:00 AM EST - 1 year ago

SELLAS Life Sciences Group Earnings release: Q3 2024


SELLAS Life Sciences Group Quarterly report: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Quarterly report: Q2 2024


SELLAS Life Sciences Group Earnings release: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Earnings release: Q2 2024


SELLAS Life Sciences Group Quarterly report: Q1 2024

May 14, 2024, 7:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Quarterly report: Q1 2024


SELLAS Life Sciences Group Earnings release: Q1 2024

May 14, 2024, 7:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Earnings release: Q1 2024


SELLAS Life Sciences Group Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Proxy statement: Proxy Filing


SELLAS Life Sciences Group Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Proxy statement: Proxy Filing


SELLAS Life Sciences Group Annual report: Q4 2023

Mar 28, 2024, 8:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Annual report: Q4 2023


SELLAS Life Sciences Group Earnings release: Q4 2023

Mar 28, 2024, 8:00 AM EDT - 2 years ago

SELLAS Life Sciences Group Earnings release: Q4 2023


SELLAS Life Sciences Group Transcript: Study Update

Mar 26, 2024, 8:15 AM EDT - 2 years ago

SELLAS Life Sciences Group Transcript: Study Update


SELLAS Life Sciences Group Press release: Study Update

Mar 26, 2024, 8:15 AM EDT - 2 years ago

SELLAS Life Sciences Group Press release: Study Update


OnTheBalance
OnTheBalance Jun. 26 at 12:25 PM
$SLS @Hannibal_Smith yep, since IA, it's Sellas and its advisors who decided to collect the extra data, now at 18 months extra, to determine proportions of patients living past years 2, 3 and 4. They all keep receiving treatments for life. It's no longer like a regular TAM but like a Consumer products' growing reservoir customers. Getting bigger for years upon years and then expanding to include CR1. All living patients, and the river of death downstream turns into a trickle. $SLS
0 · Reply
Duncan74
Duncan74 Jun. 26 at 12:25 PM
$SLS Turn off share lending. You are the boss.
0 · Reply
vlucky16
vlucky16 Jun. 26 at 12:25 PM
$SLS This is the Big One!!
0 · Reply
Flkz
Flkz Jun. 26 at 12:25 PM
$SLS we halt today
0 · Reply
chuckieclam
chuckieclam Jun. 26 at 12:25 PM
$SLS AGAIN, where did all these shitbird cockroaches come from? they sniffed us out. they just float from losing money in bitcoin to losing money in tech stocks to stinkin up our beloved Sellas room..
0 · Reply
jennypeppers
jennypeppers Jun. 26 at 12:22 PM
$SLS waiting and watching for that T1 baby
0 · Reply
Johnmtnb2018
Johnmtnb2018 Jun. 26 at 12:21 PM
$SLS Let’s see if we get a T1 halt here before BO PR. Sellas has been working on a sale of the Co. since December 2025. This is not a data play anymore. Regal phase 3 data is beyond revolutionary, it will become the gold standard for oncology trials. BO coming !
0 · Reply
DWldn
DWldn Jun. 26 at 12:20 PM
$SLS Wanting a strong Weekly close today. Let's see if we get it. Above 10.98 is the Key Level. Then 15.08 could be in the scopes. Strong technicals and strong fundamentals.
2 · Reply
BamaWriter
BamaWriter Jun. 26 at 12:20 PM
$SLS I just removed 27k shares from share lending this morning. Maybe that will help a little. Well, technically I put in the request, but Fidelity told me the shares would be returned within a couple of hours.
0 · Reply
MRTunity
MRTunity Jun. 26 at 12:19 PM
$SLS THIS IS RETARDED WTF 🤷‍♂️ INTERACTIVE BROKERS SENT THIS EMAIL 📧 YESTERDAY AND AGAIN JUST NOW For the record: I have NEVER EVER nor would ever short a single share or even buy a single out contract so what is this bullshit?! Someone is f u c k e d + desperate this doesn’t explode 💥 🚀
1 · Reply
AnssiSuomesta
AnssiSuomesta Jun. 26 at 12:19 PM
$SLS Gotta catch few shares at opening!
0 · Reply
Augustwest18
Augustwest18 Jun. 26 at 12:19 PM
$SLS where I come from 79 comes before 80.Need I say more.Maybe it’s the new math.
1 · Reply
Hannibal_Smith
Hannibal_Smith Jun. 26 at 12:19 PM
$SLS In any calculation of the TAM, and peak sales … could it be they NEED TO wait for the 80 event and at least an indication of the mOS of GPS ? (Which won’t be set at 80 event) Since patients are living multiple years instead of 8-11 months … they need to know HOW LONG. How are you otherwise going to calculate peak sales? All those patients staying alive will accumulate over the years… which means a x3, x4, x5 revenue compared to what the current drugs are producing right now. Maybe it’s even not Big Pharma who wants to wait for results, but Stifel en SELLAS… since it will allow them to raise the TAM / peak sales, and thus the BO value
0 · Reply
tommy45
tommy45 Jun. 26 at 12:18 PM
$SLS updates next week this will fly
0 · Reply
FrankGelbert
FrankGelbert Jun. 26 at 12:18 PM
$SLS The picture of a gamma squeeze by self ignition! Today retails will burn the shorties and the market makers. Many options up to 12.50 at least will go into money! What an explosion!
0 · Reply
Newguy67
Newguy67 Jun. 26 at 12:17 PM
$SLS is the type of stock/investment you want to be holding over a weekend!! Don’t get caught with your pants down, hold until data readout💪🏼
0 · Reply
OnTheBalance
OnTheBalance Jun. 26 at 12:17 PM
0 · Reply
gorillasticday
gorillasticday Jun. 26 at 12:17 PM
$SLS lol i'm stupid but if the tech goes down, niotech goes u0
0 · Reply
BringDownThoseReps
BringDownThoseReps Jun. 26 at 12:17 PM
$SLS and all of them are underwater 😂
0 · Reply
OnTheBalance
OnTheBalance Jun. 26 at 12:16 PM
$SLS Change of Control!
0 · Reply
dewmoore
dewmoore Jun. 26 at 12:16 PM
The Morning Dip & The 9:30 Rip This week $SLS slides early only to explode at the opening bell Here is the exact daily blueprint of how $SLS trading flows right now: Premarket (4AM – 9:30 AM) The Action:Thin, low-volume trading (avg. **150k–250k shares**). Shorts+algos easily push the price down on zero news, hunting for retail stop-losses. The Opening Bell (9:30 AM – 11:30 AM) Retail volume floods the gates (2.5M–4M shares in 2 hours). Trapped shorts face massive triple-digit borrow fees, sparking immediate upward rips and aggressive reversals. Midday Lull (11:30 AM – 2PM) Volume drops -The stock builds a higher base and flags out while the broader biotech market adjusts. Power Hour (2PM – 4 PM) Late day momentum returns. Traders aggressively position overnight to protect against an off-hours REGAL 80th event data drop or a buyout announcement. The trend is turning heavily bullish. We've ground up from Monday's $8.30S and shattered double digits. GLTA $SLS 🚀 $LLY $JNJ
0 · Reply
Harsh1210
Harsh1210 Jun. 26 at 12:16 PM
$SLS and there goes the pre market fake gains 😂😱
0 · Reply